Key facts
- CoapTech’s last known valuation is $32.0M (Sep 2024).
- It has raised $24.4M across 4 recorded rounds; the latest was Early Stage VC ($7.1M) in Aug 2024.
- Notable investors include MedTech Innovator, National Institutes of Health, TEDCO, Good Growth Capital, Abell Foundation — 17 tracked in total.
- CoapTech has filed 4 Form Ds with the SEC since 2020, most recently Sep 2024 ($7.1M sold to 6 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for CoapTech
Funding rounds
4 roundsAbout CoapTech
Developer of invasive surgical devices designed to offer point-of-care ultrasound procedures in hollow organs. The company's devices provide a novel platform technology that combines magnetic attraction for device placement guidance and low-cost point-of-care ultrasound for visual feedback in diagnostic, and interventional, enabling medical professionals to deskill the procedure for feeding tube placement, offering a simple, safe, and affordable method.
- Sector
- Healthcare
- HQ
- Baltimore, MD, United States
- Founded
- 2016
- Employees
- 24
- Website
- coaptech.com/
- Ownership
- Privately Held (backing)
CoapTech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CoapTech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CoapTech in its N-PORT filings yet. We sweep new filings monthly.